| Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| 3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | European Union | Switzerland | Exports | Value (US$) | 2,271,836,431.00 | 2,468,512,567.04 | 2,831,832,822.00 | 3,337,540,623.92 | 3,476,326,928.86 | 5,359,355,831.55 | 6,367,759,564.20 | 6,945,804,048.28 | 7,480,238,881.85 | 8,380,782,578.18 | 8,377,775,639.15 | 9,671,315,336.09 |
| Value Growth, YoY (%) | 9.88 | 8.65 | 14.71 | 17.85 | 4.15 | 54.16 | 18.81 | 9.07 | 7.69 | 12.03 | -0.03 | 15.44 |
The value of exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union to Switzerland totalled $ 9.67 billion in 2023. Sales of commodity group 3002 from European Union to Switzerland increased by 15.4% compared to 2022: exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" went up by $ 1.29 billion (exports of commodity group 3002 from European Union to Switzerland were equal to $8.37 billion in 2022)
Exports of "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union to Switzerland accounted for 4.73% of the total merchandise exports in 2023 (total sales of goods from European Union to Switzerland were equal to $ 204 billion in 2023). The share of commodity group 3002 grew up by 0.509 p.p. in overall exports from European Union to Switzerland compared to 2022 (it was 4.22% in 2022 and cumulative exports from European Union to Switzerland were equal to $ 198 billion).
Exports of commodity group 3002 accounted for 21% of total sales of commodity group "" from European Union to Switzerland in 2023 (cumulative exports of commodity group from European Union to Switzerland were equal to $45 billion in 2023). The share of exports of commodity group 3002 in sales of commodity group from European Union to Switzerland lowered by 0.619 p.p. compared to 2022 (it was 21% in 2022, and exports of commodity group from European Union to Switzerland were $38 billion).
The share of Switzerland in total exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union was 8.9 percent (9.67 billion USD) in 2023 of 108 billion USD - the value of overall merchandise exports of commodity group 3002 from European Union in 2023. The share of Switzerland in exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union grew up by 1.34 p.p. in value terms compared to 2022 (it was 7.56 percent in 2022, and overall exports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" from European Union amounted to 110 billion USD).